Twist Bioscience
TWST
237 hedge funds and large institutions have $2.3B invested in Twist Bioscience in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 78 increasing their positions, 75 reducing their positions, and 24 closing their positions.
83% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 24
9% more funds holding
Funds holding: 218 → 237 (+19)
8% more call options, than puts
Call options by funds: $8.71M | Put options by funds: $8.05M
4% more repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 75
1.36% less ownership
Funds ownership: 117.71% → 116.35% (-1.4%)
8% less capital invested
Capital invested by funds: $2.5B → $2.3B (-$198M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$33.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$27.5M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
+$26M |
| 4 |
Millennium Management
New York
|
+$13.8M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$8.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$49.6M |
| 2 |
JP Morgan Chase
New York
|
-$36.2M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
-$13.8M |
| 4 |
D.E. Shaw & Co
New York
|
-$13.6M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$9.72M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CIA
251
Concurrent Investment Advisors
Tampa,
Florida
| – | -$375K | -10,178 | Closed |
|
|
YIH
252
Y-Intercept (HK)
Hong Kong
| – | -$328K | -8,887 | Closed |
|
|
SW
253
SteelPeak Wealth
Woodland Hills,
California
| – | -$267K | -7,249 | Closed |
|
254
Brown Advisory
Baltimore,
Maryland
| – | -$225K | -6,095 | Closed |
|
|
CC
255
Cypress Capital
Franklin,
Tennessee
| – | -$208K | -5,635 | Closed |
|
|
EC
256
EdgeRock Capital
Denver,
Colorado
| – | -$30.2K | -825 | Closed |
|
|
GWS
257
Glassman Wealth Services
Vienna,
Virginia
| – | -$4.57K | -124 | Closed |
|
|
ASN
258
Advisory Services Network
Atlanta,
Georgia
| – | -$3.39K | -92 | Closed |
|
|
AT
259
Arlington Trust
Birmingham,
Alabama
| – | -$1.58K | -43 | Closed |
|
|
GWSG
260
GPS Wealth Strategies Group
Centennial,
Colorado
| – | -$258 | -7 | Closed |
|
|
C
261
Covestor
London,
United Kingdom
| – | -$144 | -4 | -57% |
|
TWST Hedge Fund Activity: Q1 2024 in Review
237 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q1 2024, worth a combined $2.3B — down 7.9% from $2.5B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new TWST positions and 24 closed out — a net gain of 20 holders — while 78 added to existing stakes and 75 trimmed.
The largest buyer was Artisan Partners, adding an estimated $33.1M. The largest seller was Morgan Stanley, cutting an estimated $49.6M.
- 237 institutional investors held Twist Bioscience (TWST) as of Q1 2024, up from 218 in Q4 2023.
- Funds reported $2.3B of Twist Bioscience stock for Q1 2024, down 7.9% quarter-over-quarter.
- 44 funds opened new Twist Bioscience positions in Q1 2024 and 24 closed out, a net change of +20 holders.
- The largest Twist Bioscience buyer in Q1 2024 was Artisan Partners, an estimated $33.1M added.
- The largest Twist Bioscience seller in Q1 2024 was Morgan Stanley, an estimated $49.6M sold.
Based on aggregated 13F filings for Q1 2024.